Healthcare entity
Every one of those 1 sits in a single category, medical-devices. ADMA Biologics, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 4 original sources on average. We currently track 1 Healthcare story that mention Insulet Corporation, all published on July 12, 2026.
Last mentioned: Jul 12, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, medical-devices. ADMA Biologics, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 4 original sources on average. We currently track 1 Healthcare story that mention Insulet Corporation, all published on July 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Insulet Corporation. Shared-story counts are live from our verified record — not editorial picks.
Medical device makers Insulet and Embecta face class actions alleging hidden defects and demand weaknesses for insulin delivery products, causing steep investor losses.
Insulet Corporation is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
